These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 9093638)

  • 21. The impact of five years of annual ivermectin treatment on skin microfilarial loads in the onchocerciasis focus of Asubende, Ghana.
    Alley ES; Plaisier AP; Boatin BA; Dadzie KY; Remme J; Zerbo G; Samba EM
    Trans R Soc Trop Med Hyg; 1994; 88(5):581-4. PubMed ID: 7992347
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Factors Associated with Ivermectin Non-Compliance and Its Potential Role in Sustaining Onchocerca volvulus Transmission in the West Region of Cameroon.
    Senyonjo L; Oye J; Bakajika D; Biholong B; Tekle A; Boakye D; Schmidt E; Elhassan E
    PLoS Negl Trop Dis; 2016 Aug; 10(8):e0004905. PubMed ID: 27529622
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Onchocerciasis in Gilgel Ghibe River Valley southwest Ethiopia.
    Taye A; Gebre-Michael T; Taticheff S
    East Afr Med J; 2000 Feb; 77(2):116-20. PubMed ID: 10774086
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevalence and intensity of Onchocerca volvulus infection and efficacy of ivermectin in endemic communities in Ghana: a two-phase epidemiological study.
    Osei-Atweneboana MY; Eng JK; Boakye DA; Gyapong JO; Prichard RK
    Lancet; 2007 Jun; 369(9578):2021-2029. PubMed ID: 17574093
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Onchocerciasis-associated epilepsy in the Democratic Republic of Congo: Clinical description and relationship with microfilarial density.
    Siewe Fodjo JN; Mandro M; Mukendi D; Tepage F; Menon S; Nakato S; Nyisi F; Abhafule G; Wonya'rossi D; Anyolito A; Lokonda R; Hotterbeekx A; Colebunders R
    PLoS Negl Trop Dis; 2019 Jul; 13(7):e0007300. PubMed ID: 31314757
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of 5 years of annual treatment with ivermectin (Mectizan) on the prevalence and morbidity of onchocerciasis in the village of Gami in the Central African Republic.
    Kennedy MH; Bertocchi I; Hopkins AD; Meredith SE
    Ann Trop Med Parasitol; 2002 Apr; 96(3):297-307. PubMed ID: 12061976
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Onchocerciasis in the Ntui Health District of Cameroon: epidemiological, entomological and parasitological findings in relation to elimination prospects.
    Siewe Fodjo JN; Ngarka L; Njamnshi WY; Enyong PA; Zoung-Kanyi Bissek AC; Njamnshi AK
    Parasit Vectors; 2022 Nov; 15(1):444. PubMed ID: 36443885
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of 19 years of mass drug administration with ivermectin on epilepsy burden in a hyperendemic onchocerciasis area in Cameroon.
    Boullé C; Njamnshi AK; Dema F; Mengnjo MK; Siewe Fodjo JN; Bissek AZ; Suykerbuyk P; Lenou-Nanga CG; Nana-Djeunga HC; Kamgno J; Chesnais CB; Boussinesq M; Colebunders R
    Parasit Vectors; 2019 Mar; 12(1):114. PubMed ID: 30890155
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A community-based cross-sectional study of the epidemiology of onchocerciasis in unmapped villages for community directed treatment with ivermectin in Jimma Zone, southwestern Ethiopia.
    Dana D; Debalke S; Mekonnen Z; Kassahun W; Suleman S; Getahun K; Yewhalaw D
    BMC Public Health; 2015 Jul; 15():595. PubMed ID: 26130117
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The chemotherapy of onchocerciasis XX: ivermectin in combination with albendazole.
    Awadzi K; Addy ET; Opoku NO; Plenge-Bönig A; Büttner DW
    Trop Med Parasitol; 1995 Dec; 46(4):213-20. PubMed ID: 8826100
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Modelling Neglected Tropical Diseases diagnostics: the sensitivity of skin snips for Onchocerca volvulus in near elimination and surveillance settings.
    Bottomley C; Isham V; Vivas-Martínez S; Kuesel AC; Attah SK; Opoku NO; Lustigman S; Walker M; Basáñez MG
    Parasit Vectors; 2016 Jun; 9(1):343. PubMed ID: 27301567
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ivermectin: reduction in prevalence and infection intensity of Onchocerca volvulus following biannual treatments in five Guatemalan communities.
    Collins RC; Gonzales-Peralta C; Castro J; Zea-Flores G; Cupp MS; Richards FO; Cupp EW
    Am J Trop Med Hyg; 1992 Aug; 47(2):156-69. PubMed ID: 1503185
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Onchocerca volvulus infection in Tihama region - west of Yemen: Continuing transmission in ivermectin-targeted endemic foci and unveiled endemicity in districts with previously unknown status.
    Mahdy MAK; Abdul-Ghani R; Abdulrahman TAA; Al-Eryani SMA; Al-Mekhlafi AM; Alhaidari SAA; Azazy AA
    PLoS Negl Trop Dis; 2018 Mar; 12(3):e0006329. PubMed ID: 29505580
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Still mesoendemic onchocerciasis in two Cameroonian community-directed treatment with ivermectin projects despite more than 15 years of mass treatment.
    Kamga GR; Dissak-Delon FN; Nana-Djeunga HC; Biholong BD; Mbigha-Ghogomu S; Souopgui J; Zoure HG; Boussinesq M; Kamgno J; Robert A
    Parasit Vectors; 2016 Nov; 9(1):581. PubMed ID: 27842567
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A community trial of ivermectin in the onchocerciasis focus of Asubende, Ghana. I. Effect on the microfilarial reservoir and the transmission of Onchocerca volvulus.
    Remme J; Baker RH; De Sole G; Dadzie KY; Walsh JF; Adams MA; Alley ES; Avissey HS
    Trop Med Parasitol; 1989 Sep; 40(3):367-74. PubMed ID: 2617046
    [TBL] [Abstract][Full Text] [Related]  

  • 36. After a decade of annual dose mass ivermectin treatment in Cameroon and Uganda, onchocerciasis transmission continues.
    Katabarwa M; Eyamba A; Habomugisha P; Lakwo T; Ekobo S; Kamgno J; Kuete T; Ndyomugyenyi R; Onapa A; Salifou M; Ntep M; Richards FO
    Trop Med Int Health; 2008 Sep; 13(9):1196-203. PubMed ID: 18631308
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Geographical distribution and species identification of human filariasis and onchocerciasis in Bioko Island, Equatorial Guinea.
    Ta TH; Moya L; Nguema J; Aparicio P; Miguel-Oteo M; Cenzual G; Canorea I; Lanza M; Benito A; Crainey JL; Rubio JM
    Acta Trop; 2018 Apr; 180():12-17. PubMed ID: 29289559
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of five annual rounds of mass drug administration with ivermectin on onchocerciasis in Sierra Leone.
    Koroma JB; Sesay S; Conteh A; Koudou B; Paye J; Bah M; Sonnie M; Hodges MH; Zhang Y; Bockarie MJ
    Infect Dis Poverty; 2018 Apr; 7(1):30. PubMed ID: 29628019
    [TBL] [Abstract][Full Text] [Related]  

  • 39. On-going transmission of human onchocerciasis in the Massangam health district in the West Region of Cameroon: Better understanding transmission dynamics to inform changes in programmatic interventions.
    Bakajika D; Senyonjo L; Enyong P; Oye J; Biholong B; Elhassan E; Boakye D; Dixon R; Schmidt E
    PLoS Negl Trop Dis; 2018 Nov; 12(11):e0006904. PubMed ID: 30427830
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Seasonal biting pattern of Simulium damnosum s.l and its implications on onchocerciasis treatment with ivermectin.
    Adewale B; Oyerinde JP; Mafe MA
    West Afr J Med; 2008 Oct; 27(4):224-9. PubMed ID: 19469400
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.